Need professional-grade analysis? Visit stockanalysis.com
$8.67B
27.82
10,917
3.54%
Price Chart
Risk-Adjusted Performance
Eisai Co. Ltd (ESALF) Price Performance
Eisai Co. Ltd (ESALF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $30.60.
Over the past year, ESALF has traded between a low of $22.15 and a high of $35.83. The stock has gained 9.4% over this period. It is currently 14.6% below its 52-week high.
Eisai Co. Ltd has a market capitalization of $8.67B, with a price-to-earnings ratio of 27.82 and a dividend yield of 3.54%.
About Eisai Co. Ltd
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Info
- Sector
- Healthcare
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $808.19B
- EBITDA
- $89.01B
- Profit Margin
- 5.29%
- EPS (TTM)
- 1.10
- Book Value
- 19.76
Technical Indicators
- 52 Week High
- $35.83
- 52 Week Low
- $22.15
- 50 Day MA
- $30.43
- 200 Day MA
- $29.91
- Beta
- -0.19
Valuation
- Trailing P/E
- 27.82
- Forward P/E
- 32.26
- Price/Sales
- 0.01
- Price/Book
- 1.54
- Enterprise Value
- $7.99B